MDD

Click Therapeutics teams up with Otsuka on digital therapeutic for major depressive disorder
By Laura Lovett | 01:16 pm | January 03, 2019
Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs.